We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

UTZ:NYSEUtz Brands Inc Analysis

Data as of 2026-09-01 - not real-time

$14.20

Latest Price

8/10Risk

Risk Level: High

Executive Summary

The moving-average structure behind Utz Brands, Inc. is bullish at $14.20, with short-term averages leading the long-term ones. Over a rolling month the price has gained 90.6%. Relative strength is 78.9 — overbought — and the MACD signal is bearish. Watch $14.04 as support and $14.27 as the nearer resistance level.
The shares look fair at 17.0 times earnings, though no sector average was available for comparison. The 1.77% dividend yield looks stretched against payout coverage.
Risk comes out at 8 of a possible 10, a high reading. With 30-day volatility of 184.0%, a beta of 0.71 and a maximum drawdown of 50.9%, position sizing matters more than entry timing here. The wider market backdrop reads extreme greed at 94 on the fear-greed composite.
Short, medium and long-term reads agree on hold, with conviction of 1/10.

Top Market Events

UTZ Investor Announcement: Utz Brands Investigated after Company Announces $14.Snack food company Utz Brands NYSE:UTZ in Q2 CY2026 as sales only rose 1.$HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Utz Brands, Inc.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 1/10

Key Factors

  • Short-term moving averages stacked above long-term ones
  • RSI at 78.9 signals overbought conditions
  • Trading above the 200-day average of 9.47

Medium Term

1–3 years
Neutral
Model confidence: 1/10

Key Factors

  • Short-term moving averages stacked above long-term ones
  • RSI at 78.9 signals overbought conditions
  • Dividend yield of 1.77% looks stretched against payout coverage

Long Term

> 3 years
Neutral
Model confidence: 1/10

Key Factors

  • Dividend yield of 1.77% looks stretched against payout coverage
  • Negative profit margin of -2.0%
  • Negative return on equity of -3.1%

Key Metrics & Analysis

Financial Health

Revenue Growth1.40%
Profit Margin-2.00%
P/E Ratio17.0
ROE-3.11%
ROA0.07%
Debt/Equity78.59
P/B Ratio1.8
Op. Cash Flow$115.6M
Free Cash Flow$103.2M

Technical Analysis

TrendBullish
RSI78.9
Support$14.04
Resistance$14.27
MA 20$14.15
MA 50$11.53
MA 200$9.47
MACDBearish
VolumeIncreasing
Fear & Greed Index93.64

Valuation

Fair Value$2.93
Target Price$14.31
Upside/Downside0.79%
GradeFair
TypeBlend
Dividend Yield1.77%

Risk Assessment

Beta0.71
Volatility184.04%
Sector RiskLow
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.